Rate dependency, behavioral mechanisms, and behavioral pharmacology.
Drug studies need ABA thinking to explain why behavior rates change.
01Research in Context
What this study did
Hineline (1984) wrote a think-piece, not an experiment. The paper looks at why drug studies rarely explain the behavior they change.
The author says pharmacologists report that a pill slows or speeds responding, but they skip the how. They miss the reinforcement history, the contingencies, and the schedule in place.
What they found
The field had a hole. Without mechanism data, a drug effect is just a number on a graph.
N argues that only an ABA lens—rate, contingency, reinforcement—can fill that hole.
How this fits with other research
Branch (2006) flips the script. Twenty-two years later, the same lab says “use drug methods to test ABA theory.” The 1984 paper wanted ABA to save pharmacology; the 2006 paper says pharmacology can now sharpen ABA.
Parrott (1984) shares the worry. It says behavior analysis must study harder things—memory, problem solving—or fade away. Both 1984 papers push the field to widen its lab menu.
Wyatt (2009) keeps the guard up. It tells clinicians how to push back when parents ask for pills first. All three papers circle the same flag: defend and grow behavioral explanations.
Why it matters
If you write behavior plans, you already track reinforcement and rate. This paper reminds you to ask the same questions when a client starts medication. Request data on how the drug alters the contingency, not just the symptom score. Push the team to measure behavior first, pill second.
Want CEUs on This Topic?
The ABA Clubhouse has 60+ free CEUs — live every Wednesday. Ethics, supervision & clinical topics.
Join Free →Add one column to your data sheet: note the exact schedule of reinforcement in place before and after any med change.
02At a glance
03Original abstract
Behavioral pharmacology has become increasingly independent of the experimental analysis of behavior. At its beginning, behavioral pharmacology was closely related to the experimental analysis of behavior, with developments in each field aiding the other. Early attempts to systematize data in behavioral pharmacology culminated with the development of the rate-dependency concept, but as this principle was found to have more limited generality than originally was hoped, a theoretical void developed. This circumstance was followed by increased reliance on pharmacological theory as a basis for experimentation and interpretation, with an attendant decrease in emphasis on environmental variables and behavioral interpretations. Lack of interplay between behavioral pharmacology and the experimental analysis of behavior is detrimental to both disciplines because each could contribute significantly to the other. The current trend might be reversed if more research were directed at elucidating behavioral mechanisms of drug action.
Journal of the experimental analysis of behavior, 1984 · doi:10.1901/jeab.1984.42-511